Table 1.
Clinical features of healthy volunteers and patients.
| Volunteer or patient | Age | Gender | Fever durationa (days) | Laboratory characteristicsb | Radiologye | ||||
|---|---|---|---|---|---|---|---|---|---|
| WBC (×109/L) (5–12) | HsCRP (mg/L)(<5) | Specific IgMc (IU/mL) | HAdV DNAd (throat swabs/BALF) | LDH (U/L) (159–322) | Consolidation | ||||
| V1 | 1y9m | male | − | 8.6 | − | − | − | − | − |
| V2 | 2y8m | female | − | 9.0 | − | − | − | − | − |
| V3 | 2y3m | male | − | 5.7 | − | − | − | − | − |
| A1 | 2y1m | male | 13 | 10.2 | 26.5 | + | +/+ | 919 | + |
| A2 | 1y9m | female | 16 | 8.3 | 51.14 | + | +/+ | 812 | + |
| A3 | 2y8m | female | 22 | 2.8 | 10.98 | + | +/+ | 948 | + |
aFever duration from onset to normothermia. bData extracted from the first test for the children on admission. cSpecific IgM antibodies against HAdV pneumoniae were detected in 2 mL of acute phase (on admission) patient serum using a commercial ELISA kit. dHAdV pneumonia DNA was detected by real-time PCR in throat swabs or bronchoalveolar lavage fluid (BALF). eJudged by chest radiograph or CT scan in whole course of the patients.